The contribution of the glycine cleavage system to the pathogenesis of Francisella tularensis

Microbes and Infection

Volumn 16, Issue 4, 2014, Pages 300-309

  Brown, Matthew J ^a   Russo, Brian C ^a   O'Dee, Dawn M ^a   Schmitt, Deanna M ^a   Nau, Gerard J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial infections; Francisella tularensis; Glycine cleavage system; Host pathogen interactions; Metabolism; Pathogenicity

Indexed keywords

5,10-METHYLENETETRAHYDROFOLIC ACID; BACTERIAL PROTEIN; CARRIER PROTEIN; GLYCINE CLEAVAGE SYSTEM; MULTIENZYME COMPLEX; OXIDOREDUCTASE; TETRAHYDROFOLIC ACID DERIVATIVE; TRANSFERASE;

ANIMAL; C57BL MOUSE; DISEASE MODEL; FRANCISELLA TULARENSIS; GENE DELETION; GENETICS; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; TULAREMIA; VIRULENCE;

AMINO ACID OXIDOREDUCTASES; ANIMALS; BACTERIAL PROTEINS; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; FRANCISELLA TULARENSIS; GENE DELETION; MICE, INBRED C57BL; MULTIENZYME COMPLEXES; TETRAHYDROFOLATES; TRANSFERASES; TULAREMIA; VIRULENCE;

EID: 84899477889     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2013.12.003     Document Type: Article

References (48)

1. Saslaw S., Eigelsbach H.T., Prior J.A., Wilson H.E., Carhart S. Tularemia vaccine study. II. Respiratory challenge. Arch Intern Med 1961, 107:702-714.
2. McCrumb F.R. Aerosol infection of man with Pasteurella tularensis. Bacteriol Rev 1961, 25:262-267.
3. Oyston P.C., Sjostedt A., Titball R.W. Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat Rev Microbiol 2004, 2:967-978.
4. Centers for Disease Control and Prevention (CDC) DoHaHSH Possession, use, and transfer of select agents and toxins; biennial review. Final rule. Fed Regist 2012, 77:61083-61115.
5. Sjostedt A. Intracellular survival mechanisms of Francisella tularensis, a stealth pathogen. Microbes Infect 2006, 8:561-567.
6. Bosio C.M., Dow S.W. Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J Immunol 2005, 175:6792-6801.
7. Chong A., Celli J. The Francisella intracellular life cycle: toward molecular mechanisms of intracellular survival and proliferation. Front Microbiol 2010, 1:138.
8. Hall J.D., Woolard M.D., Gunn B.M., Craven R.R., Taft-Benz S., Frelinger J.A., et al. Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect Immun 2008, 76:5843-5852.
9. Conlan J.W., North R.J. Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes. Infect Immun 1992, 60:5164-5171.
10. Conlan J.W., Chen W., Shen H., Webb A., KuoLee R. Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies. Microb Pathog 2003, 34:239-248.
11. Peng K., Monack D.M. Indoleamine 2,3-dioxygenase 1 is a lung-specific innate immune defense mechanism that inhibits growth of Francisella tularensis tryptophan auxotrophs. Infect Immun 2010, 78:2723-2733.
12. Alkhuder K., Meibom K.L., Dubail I., Dupuis M., Charbit A. Identification of trkH, encoding a potassium uptake protein required for Francisella tularensis systemic dissemination in mice. PLoS ONE 2010, 5:e8966.
13. Horzempa J., O'Dee D.M., Shanks R.M., Nau G.J. Francisella tularensis DeltapyrF mutants show that replication in nonmacrophages is sufficient for pathogenesis invivo. Infect Immun 2010, 78:2607-2619.
14. Pechous R., Celli J., Penoske R., Hayes S.F., Frank D.W., Zahrt T.C. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Infect Immun 2006, 74:4452-4461.
15. Meibom K.L., Charbit A. Francisella tularensis metabolism and its relation to virulence. Front Microbiol 2010, 1:140.
16. Kikuchi G. The glycine cleavage system: composition, reaction mechanism, and physiological significance. Mol Cell Biochem 1973, 1:169-187.
17. Wehrly T.D., Chong A., Virtaneva K., Sturdevant D.E., Child R., Edwards J.A., et al. Intracellular biology and virulence determinants of Francisella tularensis revealed by transcriptional profiling inside macrophages. Cell Microbiol 2009, 11:1128-1150.
18. Twine S.M., Mykytczuk N.C., Petit M.D., Shen H., Sjostedt A., Wayne Conlan J., et al. Invivo proteomic analysis of the intracellular bacterial pathogen, Francisella tularensis, isolated from mouse spleen. Biochem Biophys Res Commun 2006, 345:1621-1633.
19. Weiss D.S., Brotcke A., Henry T., Margolis J.J., Chan K., Monack D.M. Invivo negative selection screen identifies genes required for Francisella virulence. Proc Natl Acad Sci U S A 2007, 104:6037-6042.
20. Horzempa J., Shanks R.M., Brown M.J., Russo B.C., O'Dee D.M., Nau G.J. Utilization of an unstable plasmid and the I-SceI endonuclease to generate routine markerless deletion mutants in Francisella tularensis. J Microbiol Methods 2010, 80:106-108.
21. Chamberlain R.E. Evaluation of live tularemia vaccine prepared in a chemically defined medium. Appl Microbiol 1965, 13:232-235.
22. Russo B.C., Horzempa J., O'Dee D.M., Schmitt D.M., Brown M.J., Carlson P.E., et al. A Francisella tularensis locus required for spermine responsiveness is necessary for virulence. Infect Immun 2011, 79:3665-3676.
23. Carlson P.E., Carroll J.A., O'Dee D.M., Nau G.J. Modulation of virulence factors in Francisella tularensis determines human macrophage responses. Microb Pathog 2007, 42:204-214.
24. Ravnikar P.D., Somerville R.L. Genetic characterization of a highly efficient alternate pathway of serine biosynthesis in Escherichia coli. J Bacteriol 1987, 169:2611-2617.
25. LoVullo E.D., Miller C.N., Pavelka M.S., Kawula T.H. TetR-based gene regulation systems for Francisella tularensis. Appl Environ Microbiol 2012, 78:6883-6889.
26. Kanehisa M., Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28:27-30.
27. Karsi A., Gulsoy N., Corb E., Dumpala P.R., Lawrence M.L. High-throughput bioluminescence-based mutant screening strategy for identification of bacterial virulence genes. Appl Environ Microbiol 2009, 75:2166-2175.
28. Rohmer L., Hocquet D., Miller S.I. Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis. Trends Microbiol 2011, 19:341-348.
29. Hong P.C., Tsolis R.M., Ficht T.A. Identification of genes required for chronic persistence of Brucella abortus in mice. Infect Immun 2000, 68:4102-4107.
30. Wayne L.G., Lin K.Y. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infect Immun 1982, 37:1042-1049.
31. Bogard R.W., Davies B.W., Mekalanos J.J. MetR-regulated Vibrio cholerae metabolism is required for virulence. MBio 2012, 3:e00236.
32. Scott D.A., Hickerson S.M., Vickers T.J., Beverley S.M. The role of the mitochondrial glycine cleavage complex in the metabolism and virulence of the protozoan parasite Leishmania major. J Biol Chem 2008, 283:155-165.
33. Dahal N., Abdelhamed H., Lu J., Karsi A., Lawrence M.L. Tricarboxylic acid cycle and one-carbon metabolism pathways are important in Edwardsiella ictaluri virulence. PLoS ONE 2013, 8:e65973.
34. Lam H.M., Winkler M.E. Metabolic relationships between pyridoxine (vitamin B6) and serine biosynthesis in Escherichia coli K-12. J Bacteriol 1990, 172:6518-6528.
35. Grubman A., Phillips A., Thibonnier M., Kaparakis-Liaskos M., Johnson C., Thiberge J.M., et al. Vitamin B6 is required for full motility and virulence in Helicobacter pylori. MBio 2010, 1:e00112.
36. Takeuchi H., Hirano T., Whitmore S.E., Morisaki I., Amano A., Lamont R.J. The serine phosphatase serB of Porphyromonas gingivalis suppresses IL-8 production by dephosphorylation of NF-kappaB relA/p65. PLoS Pathog 2013, 9:e1003326.
37. Rohmer L., Fong C., Abmayr S., Wasnick M., Larson Freeman T.J., Radey M., et al. Comparison of Francisella tularensis genomes reveals evolutionary events associated with the emergence of human pathogenic strains. Genome Biol 2007, 8:R102.
38. Schell M.A. Molecular biology of the LysR family of transcriptional regulators. Annu Rev Microbiol 1993, 47:597-626.
39. Forestal C.A., Malik M., Catlett S.V., Savitt A.G., Benach J.L., Sellati T.J., et al. Francisella tularensis has a significant extracellular phase in infected mice. J Infect Dis 2007, 196:134-137.
40. Canepa A., Filho J.C., Gutierrez A., Carrea A., Forsberg A.M., Nilsson E., et al. Free amino acids in plasma, red blood cells, polymorphonuclear leukocytes, and muscle in normal and uraemic children. Nephrol Dial Transplant 2002, 17:413-421.
41. Bergstrom J., Furst P., Noree L.O., Vinnars E. Intracellular free amino acid concentration in human muscle tissue. J Appl Physiol 1974, 36:693-697.
42. Woodward J.M., Sbarra A.J., Holtman D.F. The host-parasite relationship in tularemia. I. A study of the influence of Bacterium tularense on the amino acid metabolism of white rats. J Bacteriol 1954, 67:58-61.
43. Samant S., Lee H., Ghassemi M., Chen J., Cook J.L., Mankin A.S., et al. Nucleotide biosynthesis is critical for growth of bacteria in human blood. PLoS Pathog 2008, 4:e37.
44. Yoshida T., Kikuchi G. Majors pathways of serine and glycine catabolism in various organs of the rat and cock. J Biochem 1973, 73:1013-1022.
45. Alkhuder K., Meibom K.L., Dubail I., Dupuis M., Charbit A. Glutathione provides a source of cysteine essential for intracellular multiplication of Francisella tularensis. PLoS Pathog 2009, 5:e1000284.
46. Malik M., Bakshi C.S., McCabe K., Catlett S.V., Shah A., Singh R., et al. Matrix metalloproteinase 9 activity enhances host susceptibility to pulmonary infection with type A and B strains of Francisella tularensis. J Immunol 2007, 178:1013-1020.
47. KuoLee R., Harris G., Conlan J.W., Chen W. Role of neutrophils and NADPH phagocyte oxidase in host defense against respiratory infection with virulent Francisella tularensis in mice. Microbes Infect 2011, 13:447-456.
48. Zhang Y.J., Rubin E.J. Feast or famine: the host-pathogen battle over amino acids. Cell Microbiol 2013, 15:1079-1087.